Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| I01BX003296 | Elucidation of MLK3 Signaling in Hepatocellular Carcinoma | 1 | 2022 |
| I01BX004419 | Role of Microglial Hur in promoting neuroinflammation and ALS disease progression | 1 | 2022 |
| K00CA223023 | Deciphering the role of Six2 in regulating cancer stem cell properties and promoting late-stage metastasis in breast cancer. | 1 | 2022 |
| K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 1 | 2022 |
| K08EY029006 | Novel Therapeutic Strategies for Retinal Vascular Inflammation and Angiogenesis in Diabetic Retinopathy. | 1 | 2022 |
| K08HL136786 | Modulating macrophage-mediated Inflammation in cystic fibrosis | 1 | 2022 |
| K08HL141648 | Metabolic Reprogramming of Recruited Alveolar Macrophages by Arginine In Acute Lung Injury | 1 | 2022 |
| K12CA076917 | Clinical Oncology Research Program (CORP) | 1 | 2022 |
| K23AI132644 | Epigenetic Reprogramming of Monocyte Functions during Acute Uncomplicated Malaria in Kenyan Children | 1 | 2022 |
| K23AI134307 | Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine | 1 | 2022 |
| K24AR063120 | Outcomes Research in Rheumatic Diseases | 1 | 2022 |
| K99CA252153 | Dissecting the oncogenic and pro-metastatic roles of PTHLH-mediated calcium signaling in pancreatic cancer | 1 | 2022 |
| P30AR073761 | Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application) | 1 | 2022 |
| P30DK072517 | Novel small-molecule therapies for CF | 1 | 2022 |
| P41GM103493 | A Research Resource for Ultra-sensitive High Throughput Proteomics | 1 | 2022 |
| R00AA026648 | HEPATOCYTE-DERIVED MIF: A KEY CONTRIBUTOR TO ALCOHOLIC LIVER DISEASE | 1 | 2022 |
| R00CA207871 | Algorithms to link signaling pathways with transcriptional programs for precision medicine | 1 | 2022 |
| R00CA230195 | Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment | 1 | 2022 |
| R01AI033144 | The Immunogenetics of Measles Immunity | 1 | 2022 |
| R01AI121129 | Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=43